Xsensio Revenue and Competitors
Estimated Revenue & Valuation
- Xsensio's estimated annual revenue is currently $1.9M per year.
- Xsensio's estimated revenue per employee is $193,920
Employee Data
- Xsensio has 10 Employees.
- Xsensio grew their employee count by -37% last year.
Xsensio's People
| Name | Title | Email/Phone |
|---|
Xsensio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $45.3M | 204 | 1% | N/A | N/A |
#2 | $54.3M | 250 | -20% | N/A | N/A |
#3 | $108.6M | 768 | 18% | N/A | N/A |
#4 | $8.8M | 114 | 34% | N/A | N/A |
#5 | $15.9M | 150 | 7% | N/A | N/A |
#6 | $10.2M | 101 | 7% | N/A | N/A |
#7 | $3.2M | 54 | 38% | N/A | N/A |
#8 | $15.8M | 142 | 8% | N/A | N/A |
#9 | $19.2M | 95 | 6% | $125.1M | N/A |
#10 | $21.6M | 118 | 12% | N/A | N/A |
What Is Xsensio?
Xsensio develops the unique Lab-on-Skinâ„¢ sensing platform for next-gen wearables. It senses in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way. Xsensio is a B2B company, offering Lab-on-Skinâ„¢ solutions to consumer care and consumer electronics companies.
keywords:N/A
N/A
Total Funding
10
Number of Employees
$1.9M
Revenue (est)
-37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Xsensio News
KGaA, Ercon Inc., Xsensio, Analog Devices, Inc., Animas LLC, LifeSensors, Siemens, F. Hoffmann-La Roche Ltd, i-SENS, Inc., TaiDoc Technology...
Byteflies & Quad Industries, Xenoma Inc., Abbott Laboratories, Xsensio, Bloomlife, VivaLnK, Inc., and iRhythm among many others are some of...
Xsensio, Switzerland: Xsensio develops the unique Lab-on-Skin sensing platform to sense in real time biochemical information at the surface...
Other Companies in Lausanne
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 10 | 150% | N/A |
#2 | $0.7M | 10 | 11% | N/A |
#3 | N/A | 11 | 22% | N/A |
#4 | N/A | 11 | -21% | N/A |
#5 | $1.1M | 11 | 0% | N/A |